The Mary Tyler Moore Vision Initiative is modernizing staging and endpoints for diabetic eye disease. This means we are using advanced technology to catch eye damage much earlier, and changing how we measure success in clinical trials to focus on what matters most: saving a patient’s everyday vision.
– Dr. S Robert Levine
Learn more here: https://www.marytylermoore.org/our-publications/
